Evidence map›Paper›PMID 31234706›Full record

ArticleCell cycle (Georgetown, Tex.)2019

microRNA-98 protects sepsis mice from cardiac dysfunction, liver and lung injury by negatively regulating HMGA2 through inhibiting NF-κB signaling pathway.

Jingfa Zhu, Xingyu Lin, Cairong Yan, Shaodong Yang, Zhixia Zhu

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. MicroRNAs and Sepsis-Induced Cardiac Dysfunction: A Systematic Review.International journal of molecular sciences · 2020
    Pooled it
  3. MicroRNA Profiles in Critically Ill Patients.Current medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. High Mobility Group Proteins in Sepsis.Frontiers in immunology · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jingfa Zhua Department of Emergency, Quanzhou First Hospital Affiliated to Fujian Medical University , Quanzhou , China.
Xingyu Linb Department of Emergency, Fujian Medical University Union Hospital , Fuzhou , China.
Cairong Yana Department of Emergency, Quanzhou First Hospital Affiliated to Fujian Medical University , Quanzhou , China.
Shaodong Yanga Department of Emergency, Quanzhou First Hospital Affiliated to Fujian Medical University , Quanzhou , China.
Zhixia Zhua Department of Emergency, Quanzhou First Hospital Affiliated to Fujian Medical University , Quanzhou , China.
Fujian Medical University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, MicroRNA-98 (miR-98) works as a biomarker in some diseases, such as lung cancer, Schizophrenia, and breast cancer, but there still lack of studies on the function of miR-98 during sepsis. Thus, our study is conducted to figure out the function of miR-98 for the regulation of cardiac dysfunction, liver and lung injury in sepsis mice. Cecum ligation and puncture was used to establish the sepsis mice model. Next, miR-Con and agomiR-98 were injected into the tail vein of mice 48 h after modeling. Then, expression of miR-98, HMGA2, NF-κB, inflammatory factors, apoptosis-related proteins in myocardial, liver and lung tissues of septic mice were determined. Moreover, other indices that were associated with cardiac dysfunction, liver and lung injury in septic mice were detected. Finally, bioinformatics analysis and luciferase activity assay were utilized to validate the binding site between miR-98 and HMGA2. miR-98 was poorly expressed, while HMGA2, NF-κB pathway-related proteins were highly expressed in myocardial, liver, and lung tissues of mice with sepsis. Upregulated miR-98 inhibited HMGA2, NF-κB, TNF-α, IL-6, Bcl-2 and increased IL-10, Cleaved caspase-3 and Bax expression in myocardial, liver, and lung tissues of septic mice. Upregulation of miR-98 decreased LVEDP, CTn-I, BNP, ALT, AST, TBIL, LDH, and PaCO

Indexed as

AnimalsApoptosisDisease Models, AnimalHEK293 CellsHMGA2 ProteinHumansLiverLungLung InjuryMaleMiceMice, Inbred C57BLMicroRNAsMyocytes, CardiacNF-kappa BSepsisHMGA2 ProteinMicroRNAsMIRN98 microRNA, mouseNF-kappa BHMGA2MicroRNA-98sepsis

Identifiers

PMID31234706
PMCPMC6681783
OpenAlexW2955277273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.